Hemispherian
About:
Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.
Website: https://www.hemispherian.com
Top Investors: European Innovation Council, EIC Accelerator, Investinor, Kvantia, Kistefos Venture Capital
Description:
Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.
Total Funding Amount:
$17.7M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Oslo, Oslo, Norway
Founded Date:
2015-01-01
Contact Email:
info(AT)hemispherian.com
Founders:
Zeno Albisser
Number of Employees:
11-50
Last Funding Date:
2023-12-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai